Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines
Nykode Therapeutics ASA OSLO, Norway, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of n...